Congenital Zika virus (ZIKV) infection was first linked to birth defects during the American 2 outbreak 1-3 . It has been proposed that mutations unique to the Asian/American-genotype 3 explain, at least in part, the ability of Asian/American ZIKV to cause congenital Zika syndrome 4 (CZS) 4,5 . Recent studies identified mutations in ZIKV infecting humans that arose coincident 5 with the outbreak in French Polynesia and were stably maintained during subsequent spread 6 to the Americas 5 . Here we show that African ZIKV can infect and harm fetuses and that the 7 S139N mutation that has been associated with the American outbreak is not essential for fetal 8 harm. Our findings, in a vertical transmission mouse model, suggest that ZIKV will remain a 9 threat to pregnant women for the foreseeable future, including in Africa, southeast Asia, and 10 the Americas. Additional research is needed to better understand the risks associated with 11 ZIKV infection during pregnancy, both in areas where the virus is newly endemic and where it 12 has been circulating for decades. 13
(prM; S139N) that is unique to the Asian/American lineage viruses is postulated to increase 24 neurovirulence and contribute significantly to the microcephaly phenotype 5 . 25 Yuan et al. 5 recently demonstrated that S139N substantially increased ZIKV infectivity in both 26 human and mouse neural progenitor cells (NPCs), leading to restricted brain growth in an ex-27 vivo embryonic mouse brain model, as well as higher mortality rates in neonatal mice 28 following intracranial (i.c.) inoculation. However, accumulating data suggest that in endemic 29 areas, the virus has always been teratogenic [11] [12] [13] [14] . The degree to which the capacity to cause 30 fetal harm is an emergent property unique to ZIKV circulating in the Americas remains an 31 open question. 32
To more fully characterize the range of pathogenic outcomes of congenital ZIKV infection and 33 to assess the role of S139N on an alternate genetic background, we engineered the reverse 34 amino acid mutation (asparagine reverted to serine at residue 139 in the viral polyprotein) into 35 the Puerto Rican ZIKV isolate PRVABC59 (ZIKV-PR-N139S). Prior to use in mice, we 36 assessed viral infectivity and replication of ZIKV-PR-N139S in vitro using Vero cells. ZIKV-37 PR-N139S and a control virus derived from an infectious clone bearing the wild type ZIKV-38 PRVABC59 consensus sequence (ZIKV-PR-IC) gave similar growth curves (Fig. 1a ). These 39 results suggest that the "reverse substitution" N139S did not have a significant effect on either 40 infectivity or replicative capacity in vitro. Next, to assess whether N139S, in the context of the 41 PRVABC59 genome, decreased mortality in the neonatal mouse model, we inoculated one-42 day-old BALB/c mice i.c. with 10 PFU of either ZIKV-PR-IC; ZIKV-PR-N139S; a ZIKV strain 43 isolated in Cambodia in 2010 (ZIKV-CAM; FSS 13025); a low-passage African ZIKV strain 44 isolated in Senegal in 1984 (ZIKV-DAK; DAK AR 41524); or, as a control, phosphate-buffered 45 saline (PBS) . Surprisingly, and in contrast to results described by Yuan et al., i.c. inoculation 46 of both ZIKV-DAK and ZIKV-CAM resulted in 100% mortality, whereas 80% of mice 47 succumbed to ZIKV-PR-IC and 56% to ZIKV-PR-N139S by 28 days post inoculation (dpi; Fig.  48 1b). All strains caused significant mortality (log-rank test) as compared to the PBS-inoculated 49 controls (ZIKV-CAM, ZIKV-DAK: p-value < 0.0001; ZIKV-PR-IC: p-value = 0.002; ZIKV-PR-50 N139S: p-value = 0.016). ZIKV-PR-IC and ZIKV-PR-N139S mortality rates did not significantly 51 differ (Fisher's exact test p-value = 0.21). These results are consistent with other studies in 52 pregnant animal models that have provided evidence of neurovirulence and fetal demise 53 caused by ZIKV strains isolated before the American outbreak 15, 16 . 54
The previous experiments establish the ability of each ZIKV strain tested to cause lethal 55 infections in neonates, but direct intracranial inoculation does not fully recapitulate the events 56 of a natural congenital infection. To better compare the abilities of these ZIKV strains to 57 induce birth defects following vertical transmission, we used a previously established murine 58 pregnancy model for ZIKV 16, 17 , in which dams lacking type I interferon signaling (Ifnar1 -/-) 59
were crossed with wildtype sires to produce heterozygous offspring. Because they have one 60 intact Ifnar1 haplotype, these offspring more closely resemble the immune status of human 61 fetuses. Time-mated dams were inoculated subcutaneously in the footpad with 10 3 PFU of 62 ZIKV-PR-IC, ZIKV-PR-N139S, or ZIKV-DAK on embryonic day 7.5 (E7.5), corresponding to 63 the mid-to-late first trimester in humans 18 . We omitted ZIKV-CAM in the vertical transmission 64 experiment due to previous experiments demonstrating its ability to cause fetal harm in this 65 model 16 . We collected serum samples from dams at peak viremia (2 dpi) to confirm infection 66 and to sequence viral populations replicating in vivo. All dams were productively infected 67 without significant differences in titer (Student's t-test) between treatment groups (PR-IC vs. -68 PR-N139S: p-value = 0.33, t-value = 1.03, df = 10; -PR-IC vs. -DAK: p-value = 0.27, t-value = 69 1.19, df = 9; -PR-N139S vs. -DAK: p-value = 0.27, t-value = 1.19, df = 9; Fig. 1c ). Deep 70 sequencing of virus populations replicating in maternal serum confirmed that the N139S 71 mutation was stably maintained in vivo (Table 1) . Dams were monitored daily for clinical signs 72 until time of necropsy. Overt clinical signs were only evident in ZIKV-DAK-inoculated dams 73 and included hunched posture, ruffled fur, and hind limb paralysis indicative of neurotropism. 74
All ZIKV-DAK infected dams met euthanasia criteria at time of necropsy on E14.5. 75
Next, to assess fetal outcomes, ZIKV-inoculated dams were sacrificed at E14.5 and gross 76 examination of each conceptus (both fetus and placenta, when possible) revealed overt 77 differences among fetuses within pregnancies and with uninfected counterparts. In general, 78 fetuses appeared either grossly normal or abnormal, defined as being in one of the four 79 stages of embryo resorption ( Fig. 2a , c) 19 . At time of necropsy, we observed high rates of 80 resorption in both ZIKV-PR-IC-and ZIKV-PR-N139S-infected pregnancies. The proportion of 81 abnormal fetuses for the two strains did not differ significantly (53.2%, 67.3%, Fisher's exact 82 test p-value = 0.21). In contrast, ZIKV-DAK-infected pregnancies resulted in 100% resorption 83 of fetuses (Fig 2a) . Only fetuses that appeared grossly normal were included for 84 measurement of crown-rump length (CRL) to provide evidence for intrauterine growth 85 restriction (IUGR). There was a modest reduction in size in grossly normal ZIKV-PR-IC 86 fetuses. Mean CRL did not differ significantly (Student's t-test) between fetuses of ZIKV-PR-87 IC-or PBS-inoculated dams (p-value = 0.22, t-value = 1.23 , df = 54), whereas there was a 88 statistically significant (Student's t-test) reduction in mean CRL between fetuses whose dams 89 were inoculated with ZIKV-PR-IC vs. ZIKV-PR-N139S (p-value < 0.0001, t-value = 5.42, df = 90 34; Fig 2b) . This lack of evidence of severe IUGR for ZIKV-PR-IC is contrary to other studies 91 in which fetuses developed severe IUGR 16,17,20 ; however, this may be due to differences in 92 timing of challenge and necropsy 21 , virus strain, or a different standard for characterizing 93 grossly normal fetuses compared to those in a stage of resorption at a later embryonic age. 94
To confirm vertical transmission of ZIKV to the developing conceptus, viral loads were 95 measured from representative placentas and fetuses from each litter of all treatment groups 96 by quantitative RT-PCR (Fig 2d-f ). vRNA was detected in all fetuses and placentas that were 97 tested. Viral loads were significantly higher (Student's t-test) in placentas than in fetuses (p-98 value < 0.0001, t-value =5.04, df = 95; Fig Together our data show that infection with ZIKV isolates of either the African or Asian 115 lineages during pregnancy can lead to fetal harm, with varying levels of damage to maternal, 116 placental, and fetal tissues, frequently including death of the developing fetus. Likewise, 117 intracranial inoculation of neonatal mice confirmed a similar neurovirulence phenotype across 118 ZIKV lineages. The observation that a low-passage African ZIKV isolate can cause severe 119 fetal harm suggests that, for decades, ZIKV could have been causing pregnancy losses and 120 birth defects, which were either undiagnosed or attributed to other causes. If this hypothesis is 121 correct, CZS is not a new syndrome caused by a recently emerged ZIKV variant, but rather 122 an old entity that was only recognized in the large-scale American ZIKV outbreak that began 123 in 2014-15. These results provide compelling motivation to re-evaluate hypotheses explaining 124 the emergence of CZS. A lack of thorough surveillance, paired with myriad co-circulating 125 febrile illnesses, make understanding both the past and current prevalence of gestational 126 ZIKV infection and any resulting fetal outcomes in Africa challenging [23] [24] [25] N139S (S). Importantly, no single nucleotide polymorphisms were detected at residue 139 at a 173 frequency greater than 1%, nor did we detect evidence of Dezidougou virus, an insect-specific 174
Negevirus present in some ZIKV DAK AR 41524 stocks. 175
Plaque assay. All ZIKV screens from mouse tissue and titrations for virus quantification from 176 virus stocks were completed by plaque assay on Vero cell cultures. Duplicate wells were 177 infected with 0.1 ml aliquots from serial 10-fold dilutions in growth media and virus was 178 adsorbed for one hour. Following incubation, the inoculum was removed, and monolayers were 179 overlaid with 3 ml containing a 1:1 mixture of 1.2% oxoid agar and 2X DMEM (Gibco, Carlsbad, 180 CA) with 10% (vol/vol) FBS and 2% (vol/vol) penicillin/streptomycin. Cells were incubated at 181 37 °C in 5% CO2 for four days for plaque development. Cell monolayers then were stained with 182 3 ml of overlay containing a 1:1 mixture of 1.2% oxoid agar and 2X DMEM with 2% (vol/vol) 183 FBS, 2% (vol/vol) penicillin/streptomycin, and 0.33% neutral red (Gibco). Cells were incubated 184 overnight at 37 °C and plaques were counted. 185 Viral RNA isolation. Viral Mouse Necropsy. Following inoculation with ZIKV or PBS, mice were sacrificed at E14.5.
231
Tissues were carefully dissected using sterile instruments that were changed between each 232 mouse to minimize possible cross contamination. For all mice, each organ/neonate was 233 evaluated grossly in situ, removed with sterile instruments, placed in a sterile culture dish, 234 photographed, and further processed to assess viral burden and tissue distribution or banked 235 for future assays. Briefly, uterus was first removed, photographed, and then dissected to 236 remove each individual conceptus (i.e, fetus and placenta when possible). Fetuses and 237 placentas were either collected in PBS supplemented with 20% FBS and penicillin/streptomycin 238 (for plaque assays) or fixed in 4% PFA for imaging. Crown-rump length was measured by 239 tracing distance from crown of head to end of tail using ImageJ. Infection-induced resorbed 240 fetuses (~61%) were excluded from measurement analyses because they were unlikely to 241 survive if the pregnancy was allowed to progress to term. 242
Histology. Tissues were fixed in 4% paraformaldehyde for 24 hours and transferred into cold, 243 sterile DPBS until alcohol processed and embedded in paraffin. Paraffin sections (5 μm) were 244 stained with hematoxylin and eosin (H&E). Pathologists were blinded to gross pathological 245 findings when tissue sections were evaluated microscopically. The degree of pathology at the 246 maternal-fetal interface was rated on a scale of 0-4: 0 -no lesions (normal); 1 -mild changes; 2 247 -mild to moderate changes; 3 -moderate to severe changes; 4 -severe. The final scores were 248 determined as a consensus score of three independent pathologists. For each zone in the 249 placenta (myometrium, decidua, junctional zone, labyrinth, and chorionic plate/membranes) a 250 'General' overall score was determined, a score for the amount of 'Inflammation', and a score 251 Sequence analysis. Amplicon data were analyzed using a workflow we term "Zequencer 296 2017" (https://bitbucket.org/dhoconno/zequencer/src). Briefly, R1 and R2 fastq files from the 297 paired-read Illumina miSeq dataset were merged, trimmed, and normalized using the bbtools 298 package (http://jgi.doe.gov/data-and-tools/bbtools) and Seqtk (https://github.com/lh3/seqtk). 299
Bbmerge.sh was used to merge reads, and to trim primer sequences by setting the forcetrimleft 300 parameter 22. All other parameters are set to default values. These reads were then mapped to 301 the reference amplicon sequences with BBmap.sh. Reads substantially shorter than the 302 amplicon were filtered out by reformat.sh (the minlength parameter was set to the length of the 303 amplicon minus 60). Seqtk was used to subsample to 1000 reads per amplicon. Quality 304 trimming was performed on the fastq file of normalized reads by bbmap's reformat.sh (qtrim 305 parameter set to 'lr', all other parameters set to default). Novoalign 306 (http://www.novocraft.com/products/novoalign/) was used to map each read to the appropriate 307 ZIKV reference sequence: ZIKV-PRVABC59 KU501215, ZIKV DAK AR 41524 KX601166, ZIKV 308 FSS13025 JN860885. Novoalign's soft clipping feature was turned off by specifying the 309 parameter "-o FullNW". Approximate fragment length was set to 300bp, with a standard 310 deviation of 50. We used Samtools to map, sort, and create an mpileup of our reads 311 (http://samtools.sourceforge.net/). Samtools' base alignment quality (BAQ) computation was 312 turned off; otherwise, default settings were used. SNP calling was performed with VarScan's 313 mpileupcns function (http://varscan.sourceforge.net/). The minimum average quality was set to 314 30; otherwise, default settings were used. VCF files were annotated using SnpEff 35 . Accurate 315 calling of end-of-read SNPs are a known weakness of current alignment algorithms 36 ; in 316 particular, Samtools' BAQ computation feature is known to be a source of error when using 317 VarScan (http://varscan.sourceforge.net/germline-calling.html). Therefore, both Novoalign's 318 soft clipping feature and Samtools' BAQ were turned off to increase the accuracy of SNP calling 319
for SNPs occurring at the end of a read. 320 Viral stock sequences were analyzed using a modified version of the viral-ngs workflow 321 developed by the Broad Institute (http://viral-ngs.readthedocs.io/en/latest/description.html) 322 implemented in DNANexus and using bbmap local alignment in Geneious Pro (Biomatters, Ltd., 323
Auckland, New Zealand). Briefly, using the viral-ngs workflow, host-derived reads that map to a 324 human sequence database and putative PCR duplicates are removed. The remaining reads 325 were loaded into Geneious Pro and mapped to NCBI Genbank Zika virus reference sequences 326 using bbmap local alignment. Mapped reads were aligned using Geneious global alignment and 327 the consensus sequence was used for intrasample variant calling. Variants were called that fit 328 the following conditions: have a minimum p-value of 10e-60, a minimum strand bias of 10e-5 329 when exceeding 65% bias, and were nonsynonymous. 
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